STOCK TITAN

Azenta to Participate in the Baird 2023 Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Azenta, Inc. to present at Baird 2023 Global Healthcare Conference
Positive
  • Company management will participate in the conference
Negative
  • None.

BURLINGTON, Mass., Sept. 7, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Baird 2023 Global Healthcare Conference in New York, NY, on Tuesday, September 12, 2023, which includes a presentation beginning at 9:05 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations & Corporate Communications
ir@azenta.com

Sherry Dinsmore
sherry.dinsmore@azenta.com

Azenta logo (PRNewsfoto/Azenta)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-baird-2023-global-healthcare-conference-301921303.html

SOURCE Azenta

Azenta, Inc.

NASDAQ:AZTA

AZTA Rankings

AZTA Latest News

AZTA Stock Data

2.74B
49.84M
1.9%
105.44%
7.47%
Semiconductor and Related Device Manufacturing
Manufacturing
Link
United States of America
BURLINGTON

About AZTA

azenta (nasdaq: azta) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. azenta is headquartered in chelmsford, ma, with operations in north america, europe and asia. for more information, please visit www.azenta.com.